Newsroom
May 15, 2020
…will be given remdesivir and baricitinib, an anti-inflammatory used to treat rheumatoid arthritis. Others will receive remdesivir plus a placebo. Because this is a double-blind clinical trial, neither the medical…
May 15, 2020
…their health during the coronavirus pandemic. This week he discusses temperature-taking to help slow the spread and what to do if you have COVID-19 symptoms. Read and listen to the…
May 15, 2020
Dr. Fred Campbell, an internal medicine specialist from the Division of General and Hospital Medicine, answered listeners’ questions about coronavirus. He addressed concerns about starting the school year with a…
May 14, 2020
Dr. Barbara Taylor, Infectious Diseases, and Assistant City Manager Dr. Colleen Bridger answered questions about going to public places and participating in outdoor activities. Read the full story. …
May 14, 2020
Dr. Ruth Berggren, Infectious Diseases, says 80% of COVID-19 related deaths are people over the age of 64. With multiple coronavirus outbreaks at local nursing homes, one KSAT viewer asked…
May 13, 2020
…a placebo. Because this is a double-blind clinical trial, neither the medical teams nor the patients will know who has received which treatment. “Baricitineb and other drugs could block inflammation…
